Previous Article | Next Article 
Journal of Virology, March 2003, p. 3871-3877, Vol. 77, No. 6
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.6.3871-3877.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Effects of Dipeptide Insertions between Codons 69 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Primer Unblocking, Deoxynucleoside Triphosphate Inhibition, and DNA Chain Elongation
Peter R. Meyer,1 Johan Lennerstrand,2,3 Suzanne E. Matsuura,1 Brendan A. Larder,2,
and Walter A. Scott1*
University of Miami, School of Medicine, Miami, Florida,1
Virco, UK, Ltd., Cambridge, United Kingdom,2
Division of Clinical Virology, Huddinge University Hospital, S-141 86, Stockholm, Sweden3
Received 6 September 2002/
Accepted 12 December 2002
Finger insertion mutations of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) (T69S mutations followed by various dipeptide insertions) have a multinucleoside resistance phenotype that can be explained by decreased sensitivity to deoxynucleoside triphosphate (dNTP) inhibition of the nucleotide-dependent unblocking activity of RT. We show that RTs with SG or AG (but not SS) insertions have three- to fourfold-increased unblocking activity and that all three finger insertion mutations have threefold-decreased sensitivity to dNTP inhibition. The additional presence of M41L and T215Y mutations increased unblocking activity for all three insertions, greatly reduced the sensitivity to dNTP inhibition, and resulted in defects in in vitro DNA chain elongation. The DNA chain elongation defects were partially repaired by additional mutations at positions 210, 211, and 214. These results suggest that structural communication between the regions of RT defined by these mutations plays a role in the multinucleoside resistance phenotype.
* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, P.O. Box 016129, Miami, FL 33101-6129. Phone: (305) 243-6359. Fax: (305) 243-3065. E-mail:
wscott{at}med.miami.edu.
Present address: Visible Genetics, Cambridge CB4 0GA, United Kingdom.
Journal of Virology, March 2003, p. 3871-3877, Vol. 77, No. 6
0022-538X/03/$08.00+0 DOI: 10.1128/JVI.77.6.3871-3877.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Marchand, B., White, K. L., Ly, J. K., Margot, N. A., Wang, R., McDermott, M., Miller, M. D., Gotte, M.
(2007). Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir. Antimicrob. Agents Chemother.
51: 2911-2919
[Abstract]
[Full Text]
-
Lennerstrand, J., Chu, C. K., Schinazi, R. F.
(2007). Biochemical Studies on the Mechanism of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistance to 1-({beta}-D-Dioxolane)Thymine Triphosphate. Antimicrob. Agents Chemother.
51: 2078-2084
[Abstract]
[Full Text]
-
Meyer, P. R., Smith, A. J., Matsuura, S. E., Scott, W. A.
(2006). Chain-Terminating Dinucleoside Tetraphosphates Are Substrates for DNA Polymerization by Human Immunodeficiency Virus Type 1 Reverse Transcriptase with Increased Activity against Thymidine Analogue-Resistant Mutants. Antimicrob. Agents Chemother.
50: 3607-3614
[Abstract]
[Full Text]
-
Curr, K., Tripathi, S., Lennerstrand, J., Larder, B. A., Prasad, V. R.
(2006). Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro. J. Gen. Virol.
87: 419-428
[Abstract]
[Full Text]
-
Winters, M. A., Merigan, T. C.
(2005). Insertions in the Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Genes: Clinical Impact and Molecular Mechanisms. Antimicrob. Agents Chemother.
49: 2575-2582
[Full Text]
-
Smith, A. J., Meyer, P. R., Asthana, D., Ashman, M. R., Scott, W. A.
(2005). Intracellular Substrates for the Primer-Unblocking Reaction by Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Detection and Quantitation in Extracts from Quiescent- and Activated-Lymphocyte Subpopulations. Antimicrob. Agents Chemother.
49: 1761-1769
[Abstract]
[Full Text]
-
van der Hoek, L., Back, N., Jebbink, M. F., de Ronde, A., Bakker, M., Jurriaans, S., Reiss, P., Parkin, N., Berkhout, B.
(2005). Increased Multinucleoside Drug Resistance and Decreased Replicative Capacity of a Human Immunodeficiency Virus Type 1 Variant with an 8-Amino-Acid Insert in the Reverse Transcriptase. J. Virol.
79: 3536-3543
[Abstract]
[Full Text]
-
Bouchonnet, F., Dam, E., Mammano, F., de Soultrait, V., Hennere, G., Benech, H., Clavel, F., Hance, A. J.
(2005). Quantification of the Effects on Viral DNA Synthesis of Reverse Transcriptase Mutations Conferring Human Immunodeficiency Virus Type 1 Resistance to Nucleoside Analogues. J. Virol.
79: 812-822
[Abstract]
[Full Text]
-
Meyer, P. R., Smith, A. J., Matsuura, S. E., Scott, W. A.
(2004). Effects of Primer-Template Sequence on ATP-dependent Removal of Chain-terminating Nucleotide Analogues by HIV-1 Reverse Transcriptase. J. Biol. Chem.
279: 45389-45398
[Abstract]
[Full Text]
-
Boyer, P. L., Imamichi, T., Sarafianos, S. G., Arnold, E., Hughes, S. H.
(2004). Effects of the {Delta}67 Complex of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Nucleoside Analog Excision. J. Virol.
78: 9987-9997
[Abstract]
[Full Text]
-
Deval, J., Navarro, J.-M., Selmi, B., Courcambeck, J., Boretto, J., Halfon, P., Garrido-Urbani, S., Sire, J., Canard, B.
(2004). A Loss of Viral Replicative Capacity Correlates with Altered DNA Polymerization Kinetics by the Human Immunodeficiency Virus Reverse Transcriptase Bearing the K65R and L74V Dideoxynucleoside Resistance Substitutions. J. Biol. Chem.
279: 25489-25496
[Abstract]
[Full Text]
-
Matamoros, T., Franco, S., Vazquez-Alvarez, B. M., Mas, A., Martinez, M. A., Menendez-Arias, L.
(2004). Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain: EFFECT OF MUTATIONS D67N AND T215Y ON REMOVAL OF THYMIDINE NUCLEOTIDE ANALOGUES FROM BLOCKED DNA PRIMERS. J. Biol. Chem.
279: 24569-24577
[Abstract]
[Full Text]
-
White, K. L., Chen, J. M., Margot, N. A., Wrin, T., Petropoulos, C. J., Naeger, L. K., Swaminathan, S., Miller, M. D.
(2004). Molecular Mechanisms of Tenofovir Resistance Conferred by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing a Diserine Insertion after Residue 69 and Multiple Thymidine Analog-Associated Mutations. Antimicrob. Agents Chemother.
48: 992-1003
[Abstract]
[Full Text]
-
Deval, J., White, K. L., Miller, M. D., Parkin, N. T., Courcambeck, J., Halfon, P., Selmi, B., Boretto, J., Canard, B.
(2004). Mechanistic Basis for Reduced Viral and Enzymatic Fitness of HIV-1 Reverse Transcriptase Containing Both K65R and M184V Mutations. J. Biol. Chem.
279: 509-516
[Abstract]
[Full Text]
-
Marchand, B., Gotte, M.
(2003). Site-specific Footprinting Reveals Differences in the Translocation Status of HIV-1 Reverse Transcriptase: IMPLICATIONS FOR POLYMERASE TRANSLOCATION AND DRUG RESISTANCE. J. Biol. Chem.
278: 35362-35372
[Abstract]
[Full Text]